On August 10, another batch of new crown testing products independently developed by Liangzhun Industrial Co.
Since receiving a number of overseas orders at the beginning of this year, the relevant products of Liangzhun have been exported to the Moroccan and Sri Lankan markets.
At the end of July, the high-throughput new crown antigen detection product independently developed by Liangzhun Company passed the inspection of the Guangdong Medical Device Inspection Institute of the State Food and Drug Administration
The test report showed that the specificity and sensitivity of the Quantitative New Coronary Antigen Detection Kit were close to 100%, and the detection limit reached 23.
"We have successfully applied Nano SPR technology in the new crown detection field.
According to reports, Liangzhun has been committed to the world's leading research and development of biochip micro-measurement technology for a long time
At the beginning of this year, Liangzhun conducted a large number of clinical comparison experiments in overseas markets
Clinical experiments show that, compared with conventional detection methods, Quantitative Nano SPR has the advantages of high sensitivity, high specificity, high detection rate, and high negative/positive coincidence rate
As of May this year, Quanquan has obtained CE certification for 4 new crown products and entered the whitelist of the Ministry of Commerce's export of anti-epidemic materials
"Science and technology wars against the epidemic, Hubei has full horsepower, and measurement is one of the representatives
"At this stage, we are conducting concentrated research on the source of the new crown epidemic in many places in China-Delta mutant strains
The person in charge said that they are currently developing a relevant room temperature nucleic acid recognition amplification and amplification system.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
